Altimmune ALT 深 沪

Altimmune Raises $211 Million in Equity Offering

Altimmune ( ($ALT) ) just unveiled an update. On April 22, 2026, Altimmune ente...

04-25 05:17

Why Is Altimmune Stock Falling Today?

Altimmune shares fall after a $225 million offering raises dilution concerns while funding key late-stage trials.

04-23 21:30

ASGN Posts Downbeat Q1 Results, Joins Medpace, ServiceNow And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Dow futures fall 200 pts, ASGN stock drops 25.2% after missing earnings estimates. Other stocks declining in pre-market trading. Photo: Shutterstock

04-23 20:10

Altimmune prices $225M public offering of securities

Altimmune (ALT) priced an oversubscribed public offering of common stock, pre-funded warrants and accompanying common stock warrants to raise approximately $225 million in gross proceeds, according to...

04-23 12:02

美股夜盘 | Akanda Corp涨31.73%，QuantumScape涨19.15%

Akanda Corp涨31.73%；QuantumScape涨19.15%；联合租赁涨14.35%

04-23 10:01

美股夜盘 | Akanda Corp涨22.72%，QuantumScape涨20.25%

Akanda Corp涨22.72%；QuantumScape涨20.25%；联合租赁涨14.35%

04-23 09:01

美股夜盘 | Akanda Corp涨35.46%，QuantumScape涨18.60%

ANTELOPE ENTERPRISE HOLDINGS LTD涨-18.36%；Greenlane Holdings涨-16.27%；Medpace涨-13.18%

04-23 08:10

Altimmune shares are trading lower after the company announced a public offering.

Altimmune shares are trading lower after the company announced a public offerin...

04-23 04:43

Altimmune Announces Public Offering; Quantity And Termination Date Not Disclosed

Altimmune intends to use the net proceeds from this proposed offering to fund its upcoming Phase 3 trial in metabolic dysfunction-associated steatohepatitis (MASH), as well as for working capital and general corporate

04-23 04:26

Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities

04-23 03:25